-
4,4′-(1,3-Phenylenedioxy)dianiline 2479-46-1
Professional manufacturing and supply biopharmaceutical | Raw Materials | Pharmaceutical Intermediates Reagents | Materials chemistry | Polyimide monomers |
4,4′-(1,3-Phenylenedioxy)dianiline| CAS:2479-46-1 | C18H16N2O2
-
4,4′-(4,4′-Isopropylidenediphenyl-1,1′-diyldioxy)dianiline 13080-86-9
Professional manufacturing and supply biopharmaceutical | Raw Materials | Pharmaceutical Intermediates Reagents | Industrial Material Chemistry | Polyimide monomers | 4,4′-(4,4′-Isopropylidenediphenyl-1,1′-diyldioxy)dianiline | CAS:13080-86-9 | C27H26N2O2
-
(S)-3-Amino-2,3,4,5-tetrahydro-2-oxo-1H-1-benazepine-1-acetic acid 1,1-dimethyl ethyl ester 109010-60-8
Professional manufacturing and supply biopharmaceutical | Raw Materials | Pharmaceutical Intermediates Reagents | Cardiovascular Diseases | High Blood Pressure | S-ATBA | CAS:109010-60-8 | C16H22N2O3
-
(R)-2-amino-N-benzyl-3-methoxypropanamide (2R,3R)-dihydroxysuccinate 1423058-53-0
Professional manufacturing and supply biopharmaceutical | Raw Materials | Pharmaceutical Intermediates Reagents | Neurologic diseases | Antiepileptic drugs | (R)-2-amino-N-benzyl-3-methoxypropanamide (2R,3R)-dihydroxysuccinate | CAS:1423058-53-0 | C15H22N2O8
-
Lacosamide 175481-36-4
Professional manufacturing and supply biopharmaceutical | Raw Materials | Pharmaceutical Intermediates Reagents | Neurologic diseases | Antiepileptic drugs | Lacosamide | CAS:175481-36-4 | C13H18N2O3
-
4-(2-Dimethylamino)ethoxybenzylamine 20059-73-8
Professional manufacturing and supply biopharmaceutical | Raw Materials | Pharmaceutical Intermediates Reagents | Industrial API | Digestive system drugs | Itopride hydrochloride and its Intermediates | 4-(2-Dimethylamino)ethoxybenzylamine | CAS:20059-73-8 | C11H18N2O
-
Itopride 122898-67-3
Professional manufacturing and supply biopharmaceutical | Raw Materials | Pharmaceutical Intermediates Reagents | Industrial API | Digestive system drugs | Itopride hydrochloride and its Intermediates | Itopride | CAS:122898-67-3 | C20H26N2O4
-
2-(2-Ethoxyphenoxy)ethyl bromide 3259-03-8
Professional manufacturing and supply biopharmaceutical | Raw Materials | Pharmaceutical Intermediates Reagents | Industrial API | Prostatic Hyperplasia Drugs | Tamsulosin Hydrochloride Intermediates | CAS:3259-03-8 | C10H13BrO2
-
5-Acetonyl-2-methoxybenzene sulfonamide 116091-63-5
Professional manufacturing and supply biopharmaceutical | Raw Materials | Pharmaceutical Intermediates Reagents | Industrial API | Prostatic Hyperplasia Drugs | Tamsulosin Hydrochloride Intermediates | CAS:116091-63-5 | C10H13NO4S
-
4-(4-Phenylbutoxy)benzoic acid 30131-16-9
Professional manufacturing and supply biopharmaceutical | Pharmaceutical Intermediates Reagents | Raw materials | Respiratory diseases | Pranlukast Intermediates | 4-(4-Phenylbutoxy)benzoic acid | CAS:30131-16-9 | C17H18O3
-
![3′-[4-(4-Phenylbutoxy)benzoylamino]-2′-hydroxyacetophenone 136450-06-1](https://www.yisunbio.com/uploads/50.jpg)
3′-[4-(4-Phenylbutoxy)benzoylamino]-2′-hydroxyacetophenone 136450-06-1
Professional manufacturing and supply biopharmaceutical | Pharmaceutical Intermediates Reagents | Raw materials | Respiratory diseases | Pranlukast Intermediates | 3′-[4-(4-Phenylbutoxy)benzoylamino]-2′-hydroxyacetophenone | CAS:136450-06-1 | C25H25NO4
-
3′-Amino-2′-hydroxyacetophenone 70977-72-9
Professional manufacturing and supply biopharmaceutical | Pharmaceutical Intermediates Reagents | Raw materials | Respiratory diseases | Pranlukast Intermediates | 3′-Amino-2′-hydroxyacetophenone | CAS:70977-72-9 | C8H9NO2